Figure legends
Figure 1. The flow diagram of the eligible studies selection.
Figure 2. Forest plots for the meta-analysis of lncRNAGAS5 rs145204276 indel polymorphism and cancer risk. A. Allelic model (del vs. ins). B. Recessive model (del/del vs. del/ins+ ins/ins). C. Dominant model (del/del+ del/ins vs. ins/ins). D. Over-dominant model (del/ins vs. del/del+ ins/ins). E. Homozygote contrast model (del/del vs. ins/ins). F. Additive model (del/del vs. ins/del). G. Heterozygote contrast model (del/ins vs. ins/ins).
Figure 3. Forest plots for the sensitivity analysis of lncRNAGAS5 rs145204276 polymorphism and cancer risk. A. Allelic model (del vs. ins). B. Recessive model (del/del vs. del/ins+ ins/ins). C. Dominant model (del/del+ del/ins vs. ins/ins). D. Over-dominant model (del/ins vs. del/del+ ins/ins). E. Homozygote contrast model (del/del vs. ins/ins). F. Additive model (del/del vs. ins/del). G. Heterozygote contrast model (del/ins vs. ins/ins).
Figure 4. Funnel plots for the publication bias of lncRNAGAS5 rs145204276 polymorphism and cancer risk. A. Allelic model (del vs. ins). B. Recessive model (del/del vs. del/ins+ ins/ins). C. Dominant model (del/del+ del/ins vs. ins/ins). D. Over-dominant model (del/ins vs. del/del+ ins/ins). E. Homozygote contrast model (del/del vs. ins/ins). F. Additive model (del/del vs. ins/del). G. Heterozygote contrast model (del/ins vs. ins/ins).